ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3130

Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare®

Puja Khanna1, Aaron Rankin2, Veronica Berrocal3, Larry An4 and Dinesh Khanna5, 1Rheumatology, University of Michigan, Ann Arbor, MI, 2Medicine Rheumatology, University of Michigan, Ann Arbor, MI, 3Biostatistics, University of Michigan, Ann Arbor, MI, 4Medicine, University of Michigan, Ann Arbor, MI, 5University of Michigan, Ann Arbor, MI

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Education, gout and online resources, patient

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Metabolic and Crystal Arthropathies II: Clinical Practice

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose:  Recent management guidelines for gout have identified several unmet educational needs in gout patients. Qualitative studies have documented the paucity of patient-focused materials which facilitate ongoing patient-physician communication. Our objective was to develop and test a web-based interactive educational resource (electronic platform) for gout patients tailored to improve their knowledge and help facilitate communication with their physicians.

Methods:  The website was developed in four phases: 1. Two advisory panels – 30 gout patients and 10 gout experts iteratively a) reviewed pre-identified content areas of modifiable gaps in pathogenesis, natural history and treatment goals from previously conducted focus groups1 and b) evaluated the design (graphics and lay out) of the website. 2. Incorporation of a validated Gout Knowledge Questionnaire (GKQ)2 on gout and a 5-minute post-survey to assess knowledge about critical take-home messages and satisfaction with their physician’s care. 3. A team of web designers and health informatics experts tailored the content areas on the website to create a patient journey to learn various aspects of gout such as triggers of flares, comorbidities, pharmacologic and non-pharmacologic treatments, healthy gout diet, and lifestyle choices. 4. Beta testing was performed by 10 patients with gout in clinics for clarity and usability. The website is called MyGoutCare® and in the pilot study, the patient completes a baseline survey of demographics and gout knowledge, reviews the website and generates a list of customized questions (MyGoutReport®) to discuss at the upcoming visit with their physician. They next complete a post-survey within two weeks of the physician visit. Data was analyzed using a paired t-test and presented as mean change in scores between post and baseline surveys.

Results:  The pilot study recruited 50 subjects with gout from general medicine, podiatry, and rheumatology clinics. The mean age was 54 years, 88% were males, 82% Caucasian, and 68% consumed 7.5 drinks per week. Disease duration was 9.5 years and they reported 3-5 flares per year. All subjects were extremely receptive of the e-learning tool that was accessible 24/7. Post-survey scores on GKQ (mean score= 9.06, 0-10) improved significantly (20%) when compared to pre-survey scores (mean score= 7.12) with mean (SD) at 1.95 (1.93), p<0.0001 and effect size of 0.95. All subjects reported satisfaction with discussion on the natural history of disease and treatment choices with their physicians. They reported significant actionable changes moving forward, such as changing urate-lowering therapy (72%) and dietary/alcohol changes (28%-38%) to achieve flare-free status.

Conclusion:  Our pilot study suggests that web-based patient-focused materials can serve as a practical tool to positively impact the ongoing educational needs of patients in a busy clinical practice setting. Prospective adequately powered studies are needed to evaluate if this online tool will lead to better long term outcomes by improving patient-physician communication. References: 1Khanna P. Ann Rheum Dis. 2013;72(Suppl3):768. 2Zhang LY. J Clin Rheumatol. 2011 Aug;17(5):242-8.


Disclosure: P. Khanna, AstraZeneca, 2; A. Rankin, None; V. Berrocal, None; L. An, None; D. Khanna, Bristol-Myers Squibb, 2,Pfizer Inc, 2,Roche Pharmaceuticals, 5,Sanofi-Aventis Pharmaceutical, 5,BAYER, 5,CYTORI, 5,EMD Serono, 5,Roche Pharmaceuticals, 2,AstraZeneca, 5.

To cite this abstract in AMA style:

Khanna P, Rankin A, Berrocal V, An L, Khanna D. Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare® [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/development-and-pilot-testing-of-an-online-educational-tool-for-gout-patients-mygoutcare/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-pilot-testing-of-an-online-educational-tool-for-gout-patients-mygoutcare/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology